| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $901M | — | — | — | — |
| Op. Income | $109M | — | — | — | — |
| Gross Margin | 44.4% | — | — | — | — |
| Net Margin | 10.4% | — | — | — | — |
| EPS (Diluted) | $1.37 | — | — | — | — |
| Free Cash Flow | -$67M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $901M |
| Cost of Revenue | $501M |
| GROSS PROFIT | $400M |
| R&D Expenses | $145M |
| Selling & Marketing | $77M |
| General & Administrative | $69M |
| SG&A Expenses | $146M |
| Other Expenses | $0 |
| Operating Expenses | $291M |
| Cost & Expenses | $792M |
| OPERATING INCOME | $109M |
| Interest Income | $15M |
| Interest Expense | $7M |
| Other Income/Expenses | $26M |
| INCOME BEFORE TAX | $135M |
| Income Tax Expense | $13M |
| Net Income from Continuing Ops | $122M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $94M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $94M |
| D&A | $16M |
| EBIT | $142M |
| EBITDA | $158M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $901M |
| Cost of Revenue | $501M |
| GROSS PROFIT | $400M |
| R&D Expenses | $145M |
| Selling & Marketing | $77M |
| General & Administrative | $69M |
| SG&A Expenses | $146M |
| Other Expenses | $0 |
| Operating Expenses | $291M |
| Cost & Expenses | $792M |
| OPERATING INCOME | $109M |
| Interest Income | $15M |
| Interest Expense | $7M |
| Other Income/Expenses | $26M |
| INCOME BEFORE TAX | $135M |
| Income Tax Expense | $13M |
| Net Income from Continuing Ops | $122M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $94M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $94M |
| D&A | $16M |
| EBIT | $142M |
| EBITDA | $158M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $94M |
| Depreciation & Amortization | $16M |
| Stock-Based Compensation | $34M |
| Deferred Income Tax | -$14M |
| Other Non-Cash Items | $38M |
| Change in Working Capital | -$178M |
| OPERATING CASH FLOW | -$10M |
| Capital Expenditure | -$56M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$484.0K |
| Sales/Maturities of Investments | $2M |
| Other Investing Activities | -$336M |
| NET CASH FROM INVESTING | -$390M |
| Net Debt Issuance | $99M |
| Common Stock Repurchased | -$7M |
| Common Dividends Paid | -$8M |
| Other Financing Activities | $242.0K |
| NET CASH FROM FINANCING | $742M |
| FREE CASH FLOW | -$67M |
| Net Change in Cash | $355M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $766M |
| Short-Term Investments | $402M |
| Net Receivables | $553M |
| Inventory | $703M |
| Other Current Assets | $3M |
| TOTAL CURRENT ASSETS | $2.4B |
| PP&E (Net) | $333M |
| Goodwill | $0 |
| Intangible Assets | $3M |
| Long-Term Investments | $66M |
| Tax Assets | $29M |
| Other Non-Current Assets | $4M |
| TOTAL NON-CURRENT ASSETS | $436M |
| TOTAL ASSETS | $2.9B |
| Account Payables | $248M |
| Short-Term Debt | $114M |
| Deferred Revenue | $205M |
| Other Current Liabilities | $178M |
| TOTAL CURRENT LIABILITIES | $746M |
| Long-Term Debt | $184M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $7M |
| TOTAL NON-CURRENT LIABILITIES | $196M |
| TOTAL LIABILITIES | $942M |
| Common Stock | $7.0K |
| Additional Paid-In Capital | $1.1B |
| Retained Earnings | $350M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$2M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $1.5B |
| Minority Interest | $466M |
| TOTAL EQUITY | $1.9B |
| TOTAL LIABILITIES & EQUITY | $2.9B |
| Total Debt | $303M |
| Net Debt | -$463M |
